You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑞麗醫美(02135.HK)預計年度由盈轉虧1800萬元
格隆匯 01-28 18:36

格隆匯1月28日丨瑞麗醫美(02135.HK)公吿,董事會預期集團將於截至2021年12月31日止年度錄得收入約人民幣188百萬元(2020年:收入約人民幣165百萬元)。

及董事會預期集團將於該年度錄得歸屬於母公司股東的虧損約人民幣18百萬元(2020年:溢利約人民幣4百萬元)。

董事會認為,收入增加及由盈轉虧的主要原因如下:(a)杭州及浙江地區醫療機構業務受到自2021年11月起杭州及浙江政府施加的近一個月的限制出行新措施及嚴格管控政策(的影響,導致(i)於11、12月份取消雙十一活動中的線上銷售訂單金額約人民幣21百萬元;及(ii)公司無法於短期內調整已為雙十一及雙十二活動做好準備的員工結構(新營銷團隊),以致於公司的員工成本較2020年有所上升。

(b)為了加快恢復疫情前集團的銷售業績並配合集團業務發展,該年度公司的銷售及分銷開支約人民幣54百萬元(2020年:開支約人民幣33百萬元),同比增長人民幣21百萬元;該等開支增長在本年度未能達到預期效果,主要由於雙十一及雙十二的市場推廣活動及集團品牌推廣受到新管控措施的影響。

及(c)公司證券於香港聯合交易所有限公司上市所募集的所得款項以港元計值,該年度產生約人民幣2百萬元的匯兑虧損(2020年:虧損約人民幣0.3百萬元)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account